Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Hexamine Hippurate
2. Hip-rex
3. Hiprex
4. Urex
5. Urotractan
1. 5714-73-8
2. Hiprex
3. Hexamine Hippurate
4. Hexamethylenetetramine Monohippurate
5. Hexamethylenetetramine Hippurate
6. 1,3,5,7-tetraazaadamantane Benzoylglycinate
7. Methenamine (hippurate)
8. Hippramine
9. Haiprex
10. Viapta
11. 2-benzamidoacetic Acid;1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane
12. M329791l57
13. Glycine, N-benzoyl, Compd. With 1,3,5,7-tetraazatricyclo(3.3.1.1(sup 3,7))decane (1:1)
14. Hexamethylenetetramine Monohippurate;hexamethylenetetramine Monohippurate
15. Methenamine Hippurate [usan]
16. R-657
17. Einecs 227-206-5
18. Hexamethylene Tetramine Hippurate
19. Unii-m329791l57
20. Hiprex (tn)
21. Urex (tn)
22. Hippuric Acid, Compd. With Hexamethylenetetramine (1:1)
23. Methenamine Hippurate [usan:usp:inn:ban]
24. Schembl3029
25. Chebi:6825
26. Chembl1201104
27. Dtxsid10972603
28. Methenamine Hippurate (jan/usp)
29. Methenamine Hippurate [jan]
30. Hy-b1691
31. Methenamine Hippurate [vandf]
32. Mfcd00072147
33. S9466
34. Methenamine Hippurate [mart.]
35. Akos037645132
36. Methenamine Hippurate [usp-rs]
37. Methenamine Hippurate [who-dd]
38. N-benzoylglycine, Compound With 1,3,5,7-tetraazatricyclo(3.3.1.13,7)decane (1:1)
39. Methenamine Hippurate (200 Mg)
40. As-57463
41. Methenamine Hippurate [orange Book]
42. Methenamine Hippurate [usp Impurity]
43. Cs-0013675
44. Ft-0671059
45. Methenamine Hippurate [usp Monograph]
46. D00855
47. D81437
48. 714m738
49. Q27283414
50. 1,3,5,7-tetraazatricyclo[3.3.1.1(3),?]decane; 2-(phenylformamido)acetic Acid
51. N-[hydroxy(phenyl)methylidene]glycine--1,3,5,7-tetraazatricyclo[3.3.1.1~3,7~]decane (1/1)
Molecular Weight | 319.36 g/mol |
---|---|
Molecular Formula | C15H21N5O3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 3 |
Exact Mass | 319.16443955 g/mol |
Monoisotopic Mass | 319.16443955 g/mol |
Topological Polar Surface Area | 79.4 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 282 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Hiprex |
Drug Label | Each yellow capsule-shaped tablet contains 1 g Methenamine Hippurate which is the Hippuric Acid Salt of Methenamine (hexamethylene tetramine). The tablet also contains inactive ingredients. FD&C Yellow No. 5 (tartrazine, see PRECAUTIONS), Magnesium S. |
Active Ingredient | Methenamine hippurate |
Dosage Form | Tablet |
Route | Oral |
Strength | 1gm |
Market Status | Prescription |
Company | Sanofi Aventis Us |
2 of 4 | |
---|---|
Drug Name | Methenamine hippurate |
PubMed Health | Methenamine (By mouth) |
Drug Classes | Antiseptic |
Drug Label | Methenamine Hippurate Tablets are a urinary tract antiseptic drug. Each white, scored tablet contains methenamine hippurate 1g (see HOW SUPPLIED). Methenamine Hippurate Tablets also contain: magnesium stearate, povidone and saccharin sodium. Chemical... |
Active Ingredient | Methenamine hippurate |
Dosage Form | Tablet |
Route | Oral |
Strength | 1gm |
Market Status | Prescription |
Company | Corepharma |
3 of 4 | |
---|---|
Drug Name | Hiprex |
Drug Label | Each yellow capsule-shaped tablet contains 1 g Methenamine Hippurate which is the Hippuric Acid Salt of Methenamine (hexamethylene tetramine). The tablet also contains inactive ingredients. FD&C Yellow No. 5 (tartrazine, see PRECAUTIONS), Magnesium S. |
Active Ingredient | Methenamine hippurate |
Dosage Form | Tablet |
Route | Oral |
Strength | 1gm |
Market Status | Prescription |
Company | Sanofi Aventis Us |
4 of 4 | |
---|---|
Drug Name | Methenamine hippurate |
PubMed Health | Methenamine (By mouth) |
Drug Classes | Antiseptic |
Drug Label | Methenamine Hippurate Tablets are a urinary tract antiseptic drug. Each white, scored tablet contains methenamine hippurate 1g (see HOW SUPPLIED). Methenamine Hippurate Tablets also contain: magnesium stearate, povidone and saccharin sodium. Chemical... |
Active Ingredient | Methenamine hippurate |
Dosage Form | Tablet |
Route | Oral |
Strength | 1gm |
Market Status | Prescription |
Company | Corepharma |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Anti-Infective Agents, Urinary
Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
73
PharmaCompass offers a list of Methenamine Hippurate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methenamine Hippurate manufacturer or Methenamine Hippurate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methenamine Hippurate manufacturer or Methenamine Hippurate supplier.
PharmaCompass also assists you with knowing the Methenamine Hippurate API Price utilized in the formulation of products. Methenamine Hippurate API Price is not always fixed or binding as the Methenamine Hippurate Price is obtained through a variety of data sources. The Methenamine Hippurate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hip-Rex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hip-Rex, including repackagers and relabelers. The FDA regulates Hip-Rex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hip-Rex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hip-Rex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hip-Rex supplier is an individual or a company that provides Hip-Rex active pharmaceutical ingredient (API) or Hip-Rex finished formulations upon request. The Hip-Rex suppliers may include Hip-Rex API manufacturers, exporters, distributors and traders.
click here to find a list of Hip-Rex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hip-Rex DMF (Drug Master File) is a document detailing the whole manufacturing process of Hip-Rex active pharmaceutical ingredient (API) in detail. Different forms of Hip-Rex DMFs exist exist since differing nations have different regulations, such as Hip-Rex USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hip-Rex DMF submitted to regulatory agencies in the US is known as a USDMF. Hip-Rex USDMF includes data on Hip-Rex's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hip-Rex USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hip-Rex suppliers with USDMF on PharmaCompass.
A Hip-Rex written confirmation (Hip-Rex WC) is an official document issued by a regulatory agency to a Hip-Rex manufacturer, verifying that the manufacturing facility of a Hip-Rex active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Hip-Rex APIs or Hip-Rex finished pharmaceutical products to another nation, regulatory agencies frequently require a Hip-Rex WC (written confirmation) as part of the regulatory process.
click here to find a list of Hip-Rex suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hip-Rex as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hip-Rex API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hip-Rex as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hip-Rex and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hip-Rex NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hip-Rex suppliers with NDC on PharmaCompass.
Hip-Rex Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hip-Rex GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hip-Rex GMP manufacturer or Hip-Rex GMP API supplier for your needs.
A Hip-Rex CoA (Certificate of Analysis) is a formal document that attests to Hip-Rex's compliance with Hip-Rex specifications and serves as a tool for batch-level quality control.
Hip-Rex CoA mostly includes findings from lab analyses of a specific batch. For each Hip-Rex CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hip-Rex may be tested according to a variety of international standards, such as European Pharmacopoeia (Hip-Rex EP), Hip-Rex JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hip-Rex USP).